申请人:Genentech, Inc.
公开号:US20210188775A1
公开(公告)日:2021-06-24
The invention is concerned with the compounds of formula (I) and formula (II):
and pharmaceutically acceptable salts thereof. In addition, the present invention relates to methods of using the compounds of formula (I) and formula (II) as well as pharmaceutical compositions containing such compounds. The compounds are useful in treating diseases and conditions mediated by TEAD, such as cancer.